The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback